SPL 4.35% 8.8¢ starpharma holdings limited

Ann: VivaGel BV secures TGA approval for prevention of BV, page-22

  1. 313 Posts.
    lightbulb Created with Sketch. 99
    I agree with AussieBat, the nasal spray is all hype currently and is what shot the SP up, the SP has already factored in vivagel but not FDA approval which might change the game in this area. People blame shorters for the share price but it's more likely what AB is talking about.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.